Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
This study aimed to assess vitamin D information exposure, attitudes, and practices (including the use of vitamin D and other supplements as well as serum 25(OH)D testing) among breast and prostate cancer survivors through a cross-sectional survey.
Source: 1. Introduction. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This study was a cross-sectional survey.
Source: Methods.
It should be noted that observed differences between women and men may partly reflect differences in cancer type, as all female participants were breast cancer survivors and all male participants were prostate cancer survivors ().
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D-Related Information Exposure, Attitudes, and Practices Among Prostate and Breast Cancer Survivors in Poland: Implications for Patient-Physician Communication
Cross-sectional study · Nutrients · 2026
Original publication title
Vitamin D-Related Information Exposure, Attitudes, and Practices Among Prostate and Breast Cancer Survivors in Poland: Implications for Patient: Physician Communication
© 2026 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Introduction: The potential impact of vitamin D deficiency on cancer risk and oncological management remains under investigation. The study aimed to analyse vitamin D information exposure, attitudes, and practices, including the use of vitamin D and other supplements as well as serum 25-hydroxyvitamin D [(25(OH)D)] testing, among breast cancer and prostate cancer survivors in the context of patient: physician communication. Material and methods: This cross-sectional survey included 145 breast and prostate cancer survivors (mean age 62.2 ± 9.9 years) who participated using an original, validated questionnaire.
Results: Between cancer diagnosis and survey completion, more than 52% of respondents reported vitamin D supplementation, and nearly 65% declared using supplements other than vitamin D in relation to their cancer. However, only 17.3% of respondents had been instructed by their physician to take vitamin D, and only 5.5% had been ordered by their physician to have their serum 25(OH)D levels tested. The majority of respondents (94%) perceived the need for physicians to routinely order vitamin D level tests for patients diagnosed with cancer.
Only 39.5% of vitamin D users and 7.5% of other supplement users stated that their oncology care physicians knew about their supplement intake. The most common reason for patients not to inform their physician about taking vitamin D and/or other supplements was that the physician did not ask about this issue. Almost all aspects analysed showed greater health information exposure and better communication skills with physicians among women than among men. Conclusions: It appears reasonable to improve physician: patient communication and broaden consideration of patients’ needs, which suggests a direction for further studies on the role of routine 25(OH)D testing in the standard care of patients with breast and prostate cancer.
Authors’ abstract
Introduction: The potential impact of vitamin D deficiency on cancer risk and oncological management remains under investigation. The study aimed to analyse vitamin D information exposure, attitudes, and practices, including the use of vitamin D and other supplements as well as serum 25-hydroxyvitamin D [(25(OH)D)] testing, among breast cancer and prostate cancer survivors in the context of patient: physician communication. Material and methods: This cross-sectional survey included 145 breast and prostate cancer survivors (mean age 62.2 ± 9.9 years) who participated using an original, validated questionnaire.
Results: Between cancer diagnosis and survey completion, more than 52% of respondents reported vitamin D supplementation, and nearly 65% declared using supplements other than vitamin D in relation to their cancer. However, only 17.3% of respondents had been instructed by their physician to take vitamin D, and only 5.5% had been ordered by their physician to have their serum 25(OH)D levels tested. The majority of respondents (94%) perceived the need for physicians to routinely order vitamin D level tests for patients diagnosed with cancer.
Only 39.5% of vitamin D users and 7.5% of other supplement users stated that their oncology care physicians knew about their supplement intake. The most common reason for patients not to inform their physician about taking vitamin D and/or other supplements was that the physician did not ask about this issue. Almost all aspects analysed showed greater health information exposure and better communication skills with physicians among women than among men. Conclusions: It appears reasonable to improve physician: patient communication and broaden consideration of patients’ needs, which suggests a direction for further studies on the role of routine 25(OH)D testing in the standard care of patients with breast and prostate cancer.
Publication and source details
Original title: Vitamin D-Related Information Exposure, Attitudes, and Practices Among Prostate and Breast Cancer Survivors in Poland: Implications for Patient: Physician Communication
Anita Mikołajczyk; Karolina Kaczmarczyk; Mateusz Mikołajczyk
Nutrients · 2026
* Correspondence: anita.mikolajczyk@uwm.edu.pl© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:17:55.611702+00:00
DOI: 10.3390/nu18030427 · PMC12899719